skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
organooxygen compound > sphingolipid > ceramide > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
organooxygen compound > carboxamide > ceramide > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid
organooxygen compound > sphingolipid > glycosphingolipid > glycosylceramide > n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid

اصطلاح مرجح

n-[(2s,3r,4e)-1-/{[(2r,3r,4r,5s,6r)-5-/{[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-/{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}oxan-2-yl]oxy/}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C48H89NO18

اینچی

  • InChI=1S/C48H89NO18/c1-3-5-7-9-11-13-14-15-16-18-19-21-23-25-32(53)31(49-36(54)26-24-22-20-17-12-10-8-6-4-2)30-62-46-42(60)39(57)44(34(28-51)64-46)67-48-43(61)40(58)45(35(29-52)65-48)66-47-41(59)38(56)37(55)33(27-50)63-47/h23,25,31-35,37-48,50-53,55-61H,3-22,24,26-30H2,1-2H3,(H,49,54)/b25-23+/t31-,32+,33+,34+,35+,37-,38-,39+,40+,41+,42+,43+,44+,45-,46+,47+,48-/m0/s1

اینچی‌کی

  • HJVQASFQICDJJP-GJXDXCKOSA-N

جرم

  • 968.229

جرم تک‌ایزوتوپی

  • 967.60797

اسمایلٓ

  • O1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OC[C@H](NC(=O)CCCCCCCCCCC)[C@H](O)/C=C/CCCCCCCCCCCCC)[C@H](O)[C@@H](O)[C@@H](O[C@H]3O[C@@H]([C@H](O)[C@H](O)[C@H]3O)CO)[C@H]1CO

زیرمجموعه

  • 2_STAR

مترادف دقیق

  • N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]dodecanamide

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:185377

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD